The expression of CDC45 was higher in colorectal cancer tissues than adjacent mucosa tissues, but colorectal patients with CDC45 low expression in tumor samples had worse relapse-free survival and overall survival, indicating that CDC45 might act as oncogene in early stage but have suppressor effects on cancer in advanced stage [54]. The gene discussed is CDC45; the disease is colorectal cancer.